Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

EU HTA Publication Digest: Patient Involvement in Health Technology Assessments: Lessons for EU Joint Clinical Assessments

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. 

In a recent publication, Pickaert analysed patient involvement practices in health technology assessment (HTA) across seven countries (Canada, England, Scotland, France, Germany, Spain, and Italy) to identify lessons for the EU Joint Clinical Assessment (JCA) framework. Drawing on the Acute Leukemia Advocates Network’s comparative review, the study highlighted effective approaches such as early engagement, clear frameworks, and patient capacity building. Embedding these elements into EU JCAs could set a global standard for meaningful patient participation in HTA processes.

Access the full-text article here.